Clinical Practice Guidelines, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 2.0.0-ballot built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/cqf-recommendations/ and changes regularly. See the Directory of published versions
Official URL: http://hl7.org/fhir/uv/cpg/ActivityDefinition/chf-lasix-po | Version: 2.0.0-ballot | |||
Active as of 2024-04-14 | Computable Name: CHFLASIXPO |
Activity definition to administer LASIX PO as part of a congestive heart failure pathway
Generated Narrative: ActivityDefinition
Resource ActivityDefinition "chf-lasix-po"
Profile: CPG Computable Activity Definition
CQF Knowledge capability: shareable
CQF Knowledge capability: computable
CQF Knowledge capability: publishable
CQF knowledge representation level: structured
url: http://hl7.org/fhir/uv/cpg/ActivityDefinition/chf-lasix-po
version: 2.0.0-ballot
name: CHFLASIXPO
status: active
experimental: true
date: 2024-04-14 20:00:23+0000
publisher: HL7 International / Clinical Decision Support
contact: HL7 International / Clinical Decision Support: http://www.hl7.org/Special/committees/dss
description: Activity definition to administer LASIX PO as part of a congestive heart failure pathway
jurisdiction: World (m49.htm#001)
kind: MedicationRequest
profile: CPG Medicaiton Request
code: Order a medication (CPG Activity Type Code System#order-medication)
intent: proposal
priority: routine
doNotPerform: false
product: LASIX PO (CHF Codes#lasix-po)
dosage
sequence: 1
text: 40mg
timing: Once per 1 days
route: Oral Route (qualifier value) (SNOMED CT#26643006)
doseAndRate